Analyst Ratings for Alnylam Pharmaceuticals (ALNY)

ALNY Rating Summary

ALNY Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ALNY
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $208.40 (+42.3%) * Over Last 12-Mos
Rating Score: 7.3 / 10   Percentile Rank: 74%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/27/2022 Guggenheim Debjit Chattopadhyay Downgrade Neutral
(Buy)
N/A
(N/A)
147.50
(146.49)
-0.68% Details
6/7/2022 William Blair Myles Minter New Coverage Outperform
(N/A)
N/A
(N/A)
131.63
(146.49)
11.29% Details
Like ALNY Ratings? Also take a look at BBIO, MRNA, CYRX, BHG

ALNY Ratings News